Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ali T. Hassan"'
Autor:
Abeer Hassan, Yasuhiro Tsuda, Akira Asai, Keisuke Yokohama, Ken Nakamura, Tetsuya Sujishi, Hideko Ohama, Yusuke Tsuchimoto, Shinya Fukunishi, Usama M. Abdelaal, Usama A. Arafa, Ali T. Hassan, Ali M. Kassem, Kazuhide Higuchi
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
Transarterial chemoembolization (TACE) is usually followed by hepatic dysfunction. We evaluated the effects of L-carnitine on post-TACE impaired liver functions. Methods. 53 cirrhotic hepatocellular carcinoma patients at Osaka Medical College were en
Externí odkaz:
https://doaj.org/article/1f2bb20cd01c4641af4eb60121e8b913
Publikováno v:
Journal of The Egyptian Society of Nephrology and Transplantation. 16:21
Background Nephrotic syndrome is not a disease; it is the manifestation of a wide variety of underlying disease processes. Objectives The aim of the present study was to investigate different clinic-laboratory and histological patterns of nephrotic s
Autor:
Takashi Himoto, Kiyohito Kato, Kazushi Deguchi, Naohito Uchida, Adel A El-Sayed, Kazutaka Kurokohchi, Gong Jian, Kunihiko Izuishi, Hisaaki Miyoshi, Masaaki Tokuda, Hisashi Usuki, Hisakazu Iwama, Hirohito Yoneyama, Joji Tani, Masayuki Murota, Yasuyuki Suzuki, Tsutomu Masaki, Usama A. Arafa, Hisao Wakabayashi, Asahiro Morishita, Akihiro Deguchi, Liu Shi, Hamdy Saad Mohammad, Ali T. Hassan, Eman A. Sabet
Publikováno v:
International journal of oncology. 33(6)
Annexins (ANXs) constitute a family of Ca2+-dependent membrane-binding proteins; at least 20 of them have been described to date. Among these, Annexin A2 (ANXA2) has been revealed as a multi-functional protein in vitro. Its actual role in vivo, howev
Autor:
Keisuke Yokohama, Ali T. Hassan, Akira Asai, Mohamed M. Malak, Usama A. Arafa, Yusuke Tsuchimoto, Yasuhiro Tsuda, Abeer A. Hassan, Kazuhide Higuchi, Ken Nakamura, Shinya Fukunishi, Tetsuya Sujishi, Hideko Ohama, Ali Mahmoud Kassem
Publikováno v:
Gastroenterology. 148:S-1021
Background :Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage hepatocellular carcinoma (HCC) and usually followed by hepatic dysfunction that limits its efficacy. L-carnitine (4-N-trimethyl ammonium 3-hydroxybuty